
E135: IL17 and a GLP1?
Apr 30, 2026 - 11:03
Radio and PodcastLive Radio & Podcasts
New RCT in a new disease with a new drug! But is it as shiny as one would hope? Interesting discussion today about what a trial means, how it will affect practice, and how we could do better as a field. Happy holidays ev...
E117: Inebilizumab for IgG4-RD (MITIGATE) is an episode from The Evidence Based Rheumatology Podcast by Michael Putman. New RCT in a new disease with a new drug! But is it as shiny as one would hope? Interesting discussion today about what...
This episode belongs to The Evidence Based Rheumatology Podcast.
Use the player on this page to stream the episode online.
Published Dec 3, 2024, 12:55 long, audio available.
New RCT in a new disease with a new drug! But is it as shiny as one would hope? Interesting discussion today about what a trial means, how it will affect practice, and how we could do better as a field. Happy holidays everyone!
You can listen to E117: Inebilizumab for IgG4-RD (MITIGATE) online on Radio and Podcast. Open the player on this page to stream the available audio.
E117: Inebilizumab for IgG4-RD (MITIGATE) is an episode from The Evidence Based Rheumatology Podcast by Michael Putman.
This episode is 12:55 long.
This episode was published on Dec 3, 2024.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from The Evidence Based Rheumatology Podcast when more episodes are available from the podcast feed.
You can listen to E117: Inebilizumab for IgG4-RD (MITIGATE) on this page when the episode audio is available from the podcast feed.
E117: Inebilizumab for IgG4-RD (MITIGATE) is from The Evidence Based Rheumatology Podcast by Michael Putman.
Published Dec 3, 2024 and 12:55 long